Cargando…

A review: Epidemiology, pathogenesis and prospect in developing vaccines for novel Coronavirus (COVID-19)

In December 2019, a large number of coronavirus cases were emerged in Wuhan, Hubei Province, China and rapidly spread to different countries and territories around the world within four months. The World Health Organization (WHO) declared this outbreak as a global health emergency. The spread of COV...

Descripción completa

Detalles Bibliográficos
Autor principal: Gupta, Pratibha
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Tuberculosis Association of India. Published by Elsevier B.V. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7521210/
https://www.ncbi.nlm.nih.gov/pubmed/33641858
http://dx.doi.org/10.1016/j.ijtb.2020.09.021
_version_ 1783587928973246464
author Gupta, Pratibha
author_facet Gupta, Pratibha
author_sort Gupta, Pratibha
collection PubMed
description In December 2019, a large number of coronavirus cases were emerged in Wuhan, Hubei Province, China and rapidly spread to different countries and territories around the world within four months. The World Health Organization (WHO) declared this outbreak as a global health emergency. The spread of COVID-19 over globe is highly contagious; they transmitted from person-to-person through small droplets of infected person. Many diagnosis and treatment methods have been implemented to reduce and control the outbreak. Efforts have been made to develop coronavirus vaccine against S protein or spike glycoprotein of coronavirus. COVID-19 outbreak will affect the Gross Domestic Product (GDP) of the world. At the time of preparing manuscript, total number of active cases reaches to more than 8.9 million and confirmed death reaches to approx. 4.6 lakh. This article highlights the ongoing research and advances in designing vaccine and therapeutics against COVID-19 and also focusing on the epidemiology, transmission, future direction and control the spread of infectious diseases.
format Online
Article
Text
id pubmed-7521210
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Tuberculosis Association of India. Published by Elsevier B.V.
record_format MEDLINE/PubMed
spelling pubmed-75212102020-09-29 A review: Epidemiology, pathogenesis and prospect in developing vaccines for novel Coronavirus (COVID-19) Gupta, Pratibha Indian J Tuberc Review Article In December 2019, a large number of coronavirus cases were emerged in Wuhan, Hubei Province, China and rapidly spread to different countries and territories around the world within four months. The World Health Organization (WHO) declared this outbreak as a global health emergency. The spread of COVID-19 over globe is highly contagious; they transmitted from person-to-person through small droplets of infected person. Many diagnosis and treatment methods have been implemented to reduce and control the outbreak. Efforts have been made to develop coronavirus vaccine against S protein or spike glycoprotein of coronavirus. COVID-19 outbreak will affect the Gross Domestic Product (GDP) of the world. At the time of preparing manuscript, total number of active cases reaches to more than 8.9 million and confirmed death reaches to approx. 4.6 lakh. This article highlights the ongoing research and advances in designing vaccine and therapeutics against COVID-19 and also focusing on the epidemiology, transmission, future direction and control the spread of infectious diseases. Tuberculosis Association of India. Published by Elsevier B.V. 2021-01 2020-09-28 /pmc/articles/PMC7521210/ /pubmed/33641858 http://dx.doi.org/10.1016/j.ijtb.2020.09.021 Text en © 2020 Tuberculosis Association of India. Published by Elsevier B.V. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Review Article
Gupta, Pratibha
A review: Epidemiology, pathogenesis and prospect in developing vaccines for novel Coronavirus (COVID-19)
title A review: Epidemiology, pathogenesis and prospect in developing vaccines for novel Coronavirus (COVID-19)
title_full A review: Epidemiology, pathogenesis and prospect in developing vaccines for novel Coronavirus (COVID-19)
title_fullStr A review: Epidemiology, pathogenesis and prospect in developing vaccines for novel Coronavirus (COVID-19)
title_full_unstemmed A review: Epidemiology, pathogenesis and prospect in developing vaccines for novel Coronavirus (COVID-19)
title_short A review: Epidemiology, pathogenesis and prospect in developing vaccines for novel Coronavirus (COVID-19)
title_sort review: epidemiology, pathogenesis and prospect in developing vaccines for novel coronavirus (covid-19)
topic Review Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7521210/
https://www.ncbi.nlm.nih.gov/pubmed/33641858
http://dx.doi.org/10.1016/j.ijtb.2020.09.021
work_keys_str_mv AT guptapratibha areviewepidemiologypathogenesisandprospectindevelopingvaccinesfornovelcoronaviruscovid19
AT guptapratibha reviewepidemiologypathogenesisandprospectindevelopingvaccinesfornovelcoronaviruscovid19